Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1994-11-03
1996-08-13
Parr, Margaret
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241301, 4241431, 4241721, 4241741, 435 703, 435 711, 4352401, 4353201, 5303871, 53038822, 53038873, 53038875, 5303881, 5303891, 5303896, 5303897, A61K 3516, A61K 3900, A61K 39395, C07K 1600
Patent
active
055454054
ABSTRACT:
The invention relates to a CHO cell-line capable of producing antibody, the cell-line having been co-transfected with a vector capable of expressing the light chain of the antibody and a vector capable of expressing the heavy chain of the antibody wherein the vectors contain independently selectable markers; also included is a CHO cell-line capable of producing a human antibody or an altered antibody, the cell-line having been transfected with a vector capable of expressing the light chain of the antibody and the heavy chain of the antibody; process for the production of antibody using a CHO cell-line and antibody having CHO glycosylation.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5081235 (1992-01-01), Shively et al.
patent: 5089397 (1992-02-01), Kushner et al.
patent: 5219996 (1993-06-01), Bodmer et al.
Weidle, U. H., et al., Gene, 51: 21-29 (1987).
Feys, V. et al., Int. J. Cancer: Supplement 2: 26-27 (1988).
Weidle et al., Gene, 60:205-216 (1987).
Nakatani et al., Bio/Technology, 7:805-810 (1989).
Gillies et al., Bio/Technology, 7:799-804 (1989).
Kaufman et al., Mol. Cell. Biol., 5:1750-1759 (1985).
Zettlmeissl et al., Bio/Technology, 9:720-725 (1987).
Page, M. J. et al., Bio/Technology, 9 (Jan. 1991).
Goochee and Monica, Biotechnology 8 (1990), pp. 421-427.
Leatherbarrow et al., Molecular Immunology 22 (1985), pp. 407-415.
Nose and Wigzell, Proc. Nat. Acad. Sci 80 (1983), pp. 6632-6636.
Waldmann [Science 252:1657-1662 (1991)] .
Harris et al. [TIBTECH 11:42-44 (1993)].
Osband et al. [Immunotherapy 11(6):193-195 (1990)].
Dillman [Ann. Internal Med. 111:592-600 (1989)].
Hird et al. [Genes and Cancer (1990) chapter 17].
Curti [Critical Reviews in Oncology/Hematology 14:29-39 (1993)].
Alessio et al. [Nature 320:449-451 (1986)].
Riechmann et al. [Nature 332:323-327 (1988)].
Borrebaeck et al. Immunology Today 14(19):477-479 (1993).
Galili Immunology Today 14(10):480-482 (1993).
Emmery et al. Exp. Opin. Invest. Drugs 3(3):241-251 (1994).
Rademacher et al. Ann. Rev. Biochem. 57:785-838 (1988).
Hale Progress Report-MRC Wellcome Therapeutic Antibody Centre (1990).
Hale et al. Lancet 394-399 (Dec. 17, 1988).
Lim et al. Lancet 341:432-433 (1993).
Lockwood et al. Lancet 341:1620-1622 (1993).
Poynton et al. Lancet 341:1037 (1993).
Adams Donald E.
Burroughs Wellcome Co.
Parr Margaret
LandOfFree
Method for treating a mammal suffering from cancer with a cho-gl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating a mammal suffering from cancer with a cho-gl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating a mammal suffering from cancer with a cho-gl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1046496